Humana Inc. to Issue Quarterly Dividend of $0.89 (NYSE:HUM)

Humana Inc. (NYSE:HUM) announced a quarterly dividend on Thursday, August 15th, RTT News reports. Shareholders of record on Monday, September 30th will be given a dividend of 0.885 per share by the insurance provider on Friday, October 25th. This represents a $3.54 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date is Monday, September 30th.

Humana has raised its dividend payment by an average of 12.3% per year over the last three years. Humana has a payout ratio of 17.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Humana to earn $19.69 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 18.0%.

Humana Price Performance

Shares of HUM stock opened at $319.57 on Friday. Humana has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market capitalization of $38.51 billion, a price-to-earnings ratio of 19.90, a PEG ratio of 2.44 and a beta of 0.50. The stock’s 50-day simple moving average is $349.94 and its 200-day simple moving average is $344.48.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. During the same quarter in the previous year, the firm earned $8.94 EPS. Humana’s revenue was up 10.4% compared to the same quarter last year. As a group, equities analysts forecast that Humana will post 16.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have commented on HUM shares. Truist Financial lifted their price target on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. JPMorgan Chase & Co. lifted their target price on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Royal Bank of Canada increased their price target on shares of Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, September 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Finally, Piper Sandler began coverage on shares of Humana in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price objective on the stock. Thirteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $398.70.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.